Literature DB >> 34461300

Ultra-processed Foods and Risk of Crohn's Disease and Ulcerative Colitis: A Prospective Cohort Study.

Chun-Han Lo1, Neha Khandpur2, Sinara Laurini Rossato3, Paul Lochhead4, Emily W Lopes5, Kristin E Burke5, James M Richter5, Mingyang Song6, Andres Victor Ardisson Korat7, Qi Sun8, Teresa T Fung9, Hamed Khalili4, Andrew T Chan10, Ashwin N Ananthakrishnan11.   

Abstract

BACKGROUND & AIMS: The rising incidence of inflammatory bowel disease in regions undergoing Westernization has coincided with the increase in ultra-processed food (UPF) consumption over the past few decades. We aimed to examine the association between consumption of UPFs and the risk of Crohn's disease (CD) and ulcerative colitis (UC).
METHODS: We performed a prospective cohort study of 3 nationwide cohorts of health professionals in the United States-the Nurses' Health Study (1986-2014), the Nurses' Health Study II (1991-2017), and the Health Professionals Follow-up Study (1986-2012). We employed Cox proportional hazards models with adjustment for confounders to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for CD and UC according to self-reported consumption of UPFs.
RESULTS: The study included 245,112 participants. Over 5,468,444 person-years of follow-up, we documented 369 incident cases of CD and 488 incident cases of UC. The median age at diagnosis was 56 years (range, 29-85 years). Compared with participants in the lowest quartile of simple updated UPF consumption, those in the highest quartile had a significantly increased risk of CD (HR, 1.70; 95% CI, 1.23-2.35; Ptrend = .0008). Among different UPF subgroups, ultra-processed breads and breakfast foods; frozen or shelf-stable ready-to-eat/heat meals; and sauces, cheeses, spreads, and gravies showed the strongest positive associations with CD risk (HR per 1 standard deviation increase in intake, 1.18 [95% CI, 1.07-1.29], 1.11 [95% CI, 1.01-1.22], and 1.14 [95% CI, 1.02-1.27], respectively). There was no consistent association between UPF intake and UC risk.
CONCLUSIONS: Higher UPF intake was associated with an increased risk of incident CD. Further studies are needed to identify specific contributory dietary components.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Emulsifier; Epidemiology; Inflammation; Nutrition

Mesh:

Year:  2021        PMID: 34461300      PMCID: PMC8882700          DOI: 10.1016/j.cgh.2021.08.031

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   13.576


  39 in total

Review 1.  Ultra-processed products are becoming dominant in the global food system.

Authors:  C A Monteiro; J-C Moubarac; G Cannon; S W Ng; B Popkin
Journal:  Obes Rev       Date:  2013-11       Impact factor: 9.213

2.  Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.

Authors:  Arie Levine; Eytan Wine; Amit Assa; Rotem Sigall Boneh; Ron Shaoul; Michal Kori; Shlomi Cohen; Sarit Peleg; Hussein Shamaly; Avi On; Peri Millman; Lee Abramas; Tomer Ziv-Baran; Shannan Grant; Guila Abitbol; Katherine A Dunn; Joseph P Bielawski; Johan Van Limbergen
Journal:  Gastroenterology       Date:  2019-06-04       Impact factor: 22.682

3.  Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice.

Authors:  Ivan Monteleone; Irene Marafini; Vincenzo Dinallo; Davide Di Fusco; Edoardo Troncone; Francesca Zorzi; Federica Laudisi; Giovanni Monteleone
Journal:  J Crohns Colitis       Date:  2016-07-29       Impact factor: 9.071

4.  Prospective study of alcohol consumption and risk of coronary disease in men.

Authors:  E B Rimm; E L Giovannucci; W C Willett; G A Colditz; A Ascherio; B Rosner; M J Stampfer
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

5.  Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation.

Authors:  Benoit Chassaing; Tom Van de Wiele; Jana De Bodt; Massimo Marzorati; Andrew T Gewirtz
Journal:  Gut       Date:  2017-03-21       Impact factor: 23.059

6.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 7.  Ulcerative colitis.

Authors:  Ingrid Ordás; Lars Eckmann; Mark Talamini; Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2012-08-20       Impact factor: 79.321

8.  Consumption of Ultra-Processed Foods and Mortality: A National Prospective Cohort in Spain.

Authors:  Ruth Blanco-Rojo; Helena Sandoval-Insausti; Esther López-Garcia; Auxiliadora Graciani; Jose M Ordovás; Jose R Banegas; Fernando Rodríguez-Artalejo; Pilar Guallar-Castillón
Journal:  Mayo Clin Proc       Date:  2019-10-14       Impact factor: 7.616

9.   Ultra-processed food consumption and risk of obesity: a prospective cohort study of UK Biobank.

Authors:  Fernanda Rauber; Kiara Chang; Eszter P Vamos; Maria Laura da Costa Louzada; Carlos Augusto Monteiro; Christopher Millett; Renata Bertazzi Levy
Journal:  Eur J Nutr       Date:  2020-10-18       Impact factor: 5.614

10.  The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis.

Authors:  Alexander Rodriguez-Palacios; Andrew Harding; Paola Menghini; Catherine Himmelman; Mauricio Retuerto; Kourtney P Nickerson; Minh Lam; Colleen M Croniger; Mairi H McLean; Scott K Durum; Theresa T Pizarro; Mahmoud A Ghannoum; Sanja Ilic; Christine McDonald; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2018-04-23       Impact factor: 5.325

View more
  7 in total

Review 1.  The metabolic nature of inflammatory bowel diseases.

Authors:  Timon E Adolph; Moritz Meyer; Julian Schwärzler; Lisa Mayr; Felix Grabherr; Herbert Tilg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-07-29       Impact factor: 73.082

Review 2.  Multiomics to elucidate inflammatory bowel disease risk factors and pathways.

Authors:  Manasi Agrawal; Kristine H Allin; Francesca Petralia; Jean-Frederic Colombel; Tine Jess
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-17       Impact factor: 73.082

Review 3.  The Role of Diet Quality in Mediating the Association between Ultra-Processed Food Intake, Obesity and Health-Related Outcomes: A Review of Prospective Cohort Studies.

Authors:  Samuel J Dicken; Rachel L Batterham
Journal:  Nutrients       Date:  2021-12-22       Impact factor: 5.717

4.  Predictors of Anti-TNF Therapy Failure among Inflammatory Bowel Disease (IBD) Patients in Saudi Arabia: A Single-Center Study.

Authors:  Othman Alharbi; Abdulrahman M Aljebreen; Nahla A Azzam; Majid A Almadi; Maria Saeed; Baraa HajkhderMullaissa; Hassan Asiri; Abdullah Almutairi; Yazed AlRuthia
Journal:  J Clin Med       Date:  2022-07-18       Impact factor: 4.964

5.  Processed Food as a Risk Factor for the Development and Perpetuation of Crohn's Disease-The ENIGMA Study.

Authors:  Gina L Trakman; Winnie Y Y Lin; Amy L Hamilton; Amy L Wilson-O'Brien; Annalise Stanley; Jessica Y Ching; Jun Yu; Joyce W Y Mak; Yang Sun; Junkun Niu; Yinglei Miao; Xiaoqing Lin; Rui Feng; Minhu Chen; Nitin Shivappa; James R Hebert; Mark Morrison; Siew C Ng; Michael A Kamm
Journal:  Nutrients       Date:  2022-09-02       Impact factor: 6.706

6.  Maternal consumption of ultra-processed foods and subsequent risk of offspring overweight or obesity: results from three prospective cohort studies.

Authors:  Yiqing Wang; Kai Wang; Mengxi Du; Neha Khandpur; Sinara Laurini Rossato; Chun-Han Lo; Hannah VanEvery; Daniel Y Kim; Fang Fang Zhang; Jorge E Chavarro; Qi Sun; Curtis Huttenhower; Mingyang Song; Long H Nguyen; Andrew T Chan
Journal:  BMJ       Date:  2022-10-05

7.  Mendelian randomization analysis reveals causal effects of food intakes on inflammatory bowel disease risk.

Authors:  Bingxia Chen; Zemin Han; Lanlan Geng
Journal:  Front Immunol       Date:  2022-09-22       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.